Research, Innovation and Commercialisation - Research Publications

Permanent URI for this collection

http://hdl.handle.net/11343/216845

Filters

2014 1
1
Reset filters

Settings
Statistics
Citations
Author: Hansen, Diana × Author: Carbone, Francis ×

Search Results

Now showing 1 - 1 of 1
  • Item
    Thumbnail Image
    CD8+ T Cells from a Novel T Cell Receptor Transgenic Mouse Induce Liver-Stage Immunity That Can Be Boosted by Blood-Stage Infection in Rodent Malaria
    Lau, LS ; Fernandez-Ruiz, D ; Mollard, V ; Sturm, A ; Neller, MA ; Cozijnsen, A ; Gregory, JL ; Davey, GM ; Jones, CM ; Lin, Y-H ; Haque, A ; Engwerda, CR ; Nie, CQ ; Hansen, DS ; Murphy, KM ; Papenfuss, AT ; Miles, JJ ; Burrows, SR ; de Koning-Ward, T ; McFadden, GI ; Carbone, FR ; Crabb, BS ; Heath, WR ; Mota, MM (PUBLIC LIBRARY SCIENCE, 2014-05)
    To follow the fate of CD8+ T cells responsive to Plasmodium berghei ANKA (PbA) infection, we generated an MHC I-restricted TCR transgenic mouse line against this pathogen. T cells from this line, termed PbT-I T cells, were able to respond to blood-stage infection by PbA and two other rodent malaria species, P. yoelii XNL and P. chabaudi AS. These PbT-I T cells were also able to respond to sporozoites and to protect mice from liver-stage infection. Examination of the requirements for priming after intravenous administration of irradiated sporozoites, an effective vaccination approach, showed that the spleen rather than the liver was the main site of priming and that responses depended on CD8α+ dendritic cells. Importantly, sequential exposure to irradiated sporozoites followed two days later by blood-stage infection led to augmented PbT-I T cell expansion. These findings indicate that PbT-I T cells are a highly versatile tool for studying multiple stages and species of rodent malaria and suggest that cross-stage reactive CD8+ T cells may be utilized in liver-stage vaccine design to enable boosting by blood-stage infections.